Human Papilloma Virus Vaccination and Incidence of Ocular Surface Squamous Neoplasia.

about

Human Papilloma Virus Vaccination and Incidence of Ocular Surface Squamous Neoplasia.

Item

http://www.wikidata.org/entity/Q40451271

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Human Papilloma Virus Vaccination and Incidence of Ocular Surface Squamous Neoplasia.

@en

type

Item

label

Human Papilloma Virus Vaccination and Incidence of Ocular Surface Squamous Neoplasia.

@en

prefLabel

Human Papilloma Virus Vaccination and Incidence of Ocular Surface Squamous Neoplasia.

@en

P1476

Human Papilloma Virus Vaccination and Incidence of Ocular Surface Squamous Neoplasia.

@en

P2093

Annabelle de St Maurice

http://www.w3.org/2001/XMLSchema#string

Joy N Carroll

http://www.w3.org/2001/XMLSchema#string

Sahar Kohanim

http://www.w3.org/2001/XMLSchema#string

Zachary I Willis

http://www.w3.org/2001/XMLSchema#string

P2860

Ocular surface squamous neoplasia - Review of etio-pathogenesis and an update on clinico-pathological diagnosis

Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

The causal relation between human papillomavirus and cervical cancer.

Epidemiology of ocular surface squamous neoplasia in Africa

The mechanisms of UV mutagenesis.

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis

FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)

FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)

P304

57-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/IIO.0000000000000157

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27898614

http://www.w3.org/2001/XMLSchema#string

P932

6069519

http://www.w3.org/2001/XMLSchema#string